Search

everythinglearnresearchcommunity

for

Search:↓

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Feminizing hormone therapy increases kidney filtration rate.

Finasteride may lower cholesterol and slow heart disease progression.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.